WELL WELL Health Technologies Corp.
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.…
Industry Peers
Medical Care FacilitiesKey Statistics
About WELL Health Technologies (TSE: WELL)
›
WELL Health Technologies (TSE: WELL) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector.
The shares were at 3.390 CAD on 20 November 2026, down 24.7% over 52 weeks. Its 52-week range is 3.360 CAD to 5.190 CAD, and it trades at the bottom of that range.
Its market capitalisation is 869.92M CAD.
WELL Health Technologies reports return on equity of -0.9%, an operating margin of 5.1% and revenue up 11.7% year over year.
Its debt exceeds its cash by 694.56M CAD, a debt-to-equity ratio of 0.70. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 7.139 CAD is 110.6% above the current price. The next earnings report is expected on 18 March 2027.